IL10 and systemic lupus erythematosus: While our study did not detect a link between IL-10 levels and clinical manifestations or disease activity as assessed by the SLEDAI score, others have suggested that IL-10 release fluctuates according to the disease phase, further reflecting its dual role in SLE progression.